Home

Unveiling Innovations in Tricuspid Regurgitation Treatment

Novel Devices, Data, and Clinical Application CME

Friday, November 8, 2024 | 01:30 PM - 02:00 PM ET

Supported by an independent educational grant from Edwards Lifesciences.

overview

During this live webinar, an expert faculty will review and discuss the latest advances in transcatheter tricuspid interventions for the treatment of tricuspid regurgitation (TR), including the latest clinical evidence and outcomes with new devices, as well as patient selection strategies. The audience will be able to interact with the faculty via chat-submitted questions.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

Susheel Kodali, MD

Avanessians Professor of Medicine

Director, Structural Heart and Valve Center

Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

New York, New York

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

GOAL STATEMENT

The goal of this activity is for learners to be better able to improve recognition of the latest advances in transcatheter tricuspid interventions for the treatment of TR, including new devices, the latest data, and patient selection strategies.

TARGET AUDIENCE

This activity is intended for cardiologists, primary care physicians, surgeons, nurse practitioners, physician assistants, and other clinicians who treat patients with tricuspid valve regurgitation.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:[break] Have increased knowledge regarding the[list][item]Novel transcatheter treatment approaches for TR[item]Latest clinical evidence and outcomes associated with transcatheter technologies in the treatment of TR[/list] [break] Demonstrate greater confidence in their ability to[list][item]Identify patients who would benefit from novel transcatheter interventions for the treatment of TR[/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] [break] Medscape, LLC designates this live activity for a maximum of 0.5 [italic]AMA PRA Category 1 Credits[/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.